Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DB25FKEJL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,731
Award facts
- Contract value 100% obligated
- $21,731.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency for 240 units of Alecensa 150 mg capsules, valued at $21,731.14. This firm fixed-price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation. The award represents one of numerous delivery orders issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026.
Alecensa is an oncology medication used in the treatment of certain lung cancers, reflecting DMS Pharmaceutical Group's ongoing role as a critical supplier of specialty pharmaceutical products to Department of Defense healthcare facilities nationwide. The delivery order is part of the DLA's SPE2DB program, which enables the agency to procure a comprehensive range of pharmaceutical items including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities globally. DMS Pharmaceutical Group's successful competition in federal pharmaceutical procurement demonstrates the company's established capabilities in distributing complex specialty medications and maintaining reliable supply chains for Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKEJL?
SPE2DB25FKEJL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FKEJL worth?
The government has obligated $21,731 on SPE2DB25FKEJL.
Is contract SPE2DB25FKEJL an order under another contract?
Yes. SPE2DB25FKEJL is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEJL competed?
The extent of competition for SPE2DB25FKEJL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award